SCHEMBL13004271

SCHEMBL13004271

Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(Sc3ccc4nc(C(F)(F)F)[nH]c4c3)n2)[nH]n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.37
CYP2C9 P11712 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
AURKA O14965 12/20 0.34
AURKB Q96GD4 11/20 0.34
NTRK1 P04629 3/20 0.34
PLK4 O00444 2/20 0.34
AURKC Q9UQB9 2/20 0.34
ABL1 P00519 2/20 0.34
BCR P11274 2/20 0.34
BMPR1B O00238 1/20 0.34
STK25 O00506 1/20 0.34
RIOK3 O14730 1/20 0.34
CHEK1 O14757 1/20 0.34
GAK O14976 1/20 0.34
MUSK O15146 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13004668 0.92 CYP1A2 (0.37) CYP1A2CYP2C9ALDH1A1HPGDALOX15
SCHEMBL2614919 0.86 AURKB (0.47) CYP1A2CYP2C9ALDH1A1HPGDALOX15
SCHEMBL2954211 0.85 AURKA (0.37) CYP1A2CYP2C9AURKAAURKBNTRK1
SCHEMBL13004288 0.85 AURKA (0.36) ALDH1A1AURKAAURKBRIPK1
SCHEMBL13004667 0.84 AURKA (0.35) CYP1A2CYP2C9AURKAAURKBNTRK1
SCHEMBL13004285 0.84 AURKA (0.41) CYP1A2CYP2C9AURKAAURKBNTRK1
SCHEMBL2614929 0.84 AURKB (0.43) CYP1A2CYP2C9ALDH1A1HPGDALOX15
SCHEMBL13004717 0.83 AURKA (0.41) CYP1A2CYP2C9AURKAAURKBNTRK1
SCHEMBL2614905 0.83 AURKA (0.40) CYP1A2CYP2C9ALDH1A1HPGDALOX15
SCHEMBL13004233 0.82 AURKA (0.49) CYP1A2CYP2C9AURKAAURKBNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8637511-B2 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-01-28 US disclosed
US-8637511-B2 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-01-28 US disclosed
US-20100310675-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-09 US disclosed
US-20100310675-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-12-09 US disclosed
US-7767672-B2 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-08-03 US disclosed
US-7767672-B2 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-08-03 US disclosed
US-20070259869-A1 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-11-08 US disclosed
US-20070259869-A1 Aminopyrimidines useful as kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100310675-A1 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS ABL1, PRKDC, MAP3K5 CYP1A2 2591/4885CYP2C9 2457/4885ALDH1A1 2217/4885
US-20070259869-A1 Aminopyrimidines useful as kinase inhibitors ABL1, PRKDC, MAP3K5 CYP1A2 2591/4885CYP2C9 2457/4885ALDH1A1 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.